• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fredun Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5269.0
  • ISIN : INE194R01017
668.55 -14 (-2.02%)
  • As on 31 Mar 2025 (EOD)
  • Today’s Low

    660.00
  • Today’s High

    699.80
  • Open

    685.00
  • Perv Close

    682.35
  • 52W Low

    635.00
  • 52W High

    1,024.00

Key Indicators

  • P/E(TTM)

    16.79

  • Mar.Cap (₹Cr.)

    315.67

  • Div & Yield %

    0.10

  • Book Value(₹)

    277.17

  • Debt-Equity Ratio

    -2.02

  • AGM Date

    28-Mar-2025

  • EPS

    39.81

  • P/E Ratio

    16.79

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    315.67

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.72

  • BV (₹)

    277.20

  • Sales( ₹ in Cr.)

    348.16

  • NP (in Cr.)

    15.62

  • NP Var(%)

    45.0

  • Div%

    7.0

  • CPS (₹)

    41.10

  • EPS (₹)

    33.10

  • Traded Value (₹ in Lakhs)

    315.67

  • 52 Week High

    1,024.00

  • 52 Week Low

    635.00

  • Price BSE

    669.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    315.67

  • P/C Ratio

    16.30

  • P/E Ratio

    20.20

  • Price Vs.BV

    33.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 348.16 274.68 224.46 133.89 112.77 97.02
Excise Duty 346.58 274.34 221.74 131.48 110.30 95.41
Net Sales 348.16 274.68 224.46 133.89 112.77 97.02
Other Income 0.92 1.82 1.63 1.40 0.52 0.38
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 349.07 276.50 226.09 135.29 113.29 97.40
EXPENDITURE :
Raw Materials 346.58 274.34 221.74 131.48 110.30 95.41
Power & Fuel Cost 346.58 274.34 221.74 131.48 110.30 95.41
Employee Cost 12.50 11.54 10.66 8.66 8.95 8.04
Other Manufacturing Expenses 1.22 1.71 0.53 0.49 0.43 2.93
Selling & Administrative Expenses 21.52 15.38 13.05 8.31 6.69 10.39
Miscellaneous Expenses 1.22 1.71 0.53 0.49 0.43 2.93
Less : Pre-operative Expenses Capitalised :
Total Expenditure 327.62 258.99 217.49 132.08 110.79 91.24
Operating Profit 14.96 10.42 9.97 6.69 7.35 5.58
Interest 13.65 9.28 4.67 4.16 4.41 3.10
Gross Profit 21.45 17.51 8.60 3.21 2.49 6.16
Depreciation 3.80 2.81 2.16 2.00 1.88 1.33
Profit Before Tax 21.45 17.51 8.60 3.21 2.49 6.16
Tax 5.54 4.29 2.21 0.76 0.44 1.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.29 2.41 0.05 0.44 0.15 -0.02
Reported Net Profit 15.62 10.81 6.34 2.01 1.90 4.46
Extraordinary Items 21.45 17.51 8.60 3.21 2.49 6.16
Adjusted Net Profit 15.62 10.81 6.34 2.01 1.90 4.46
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.33 0.32 0.31 0.28 0.26 0.26
P & L Balance carried down 15.62 10.81 6.34 2.01 1.90 4.46
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 7.00 7.00 7.00 7.00 6.60 6.50
Dividend Per Share(Rs) 0.70 0.70 0.70 0.70 0.66 0.65
Earnings Per Share-Unit Curr 33.66 24.13 15.26 5.05 4.77 11.59
Book Value 0.33 0.32 0.31 0.28 0.26 0.26
Book Value(Adj)-Unit Curr 0.33 0.32 0.31 0.28 0.26 0.26

Shareholding Pattern

  • Promoter Group

    48.93%

  • Public Share Holding

    51.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,310,385 48.93 2,310,385 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,310,385 48.93 2,310,385 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 75,000 1.59 75,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 75,000 1.59 75,000 1
2] Non Institution
Bodies Corporate 28,550 0.60 14,450 31
Clearing Members 1,064 0.02 1,064 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 91,801 1.94 91,801 162
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 88,986 1.88 88,986 194
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 499,730 10.58 499,730 7
Individuals holding nominal share capital up to Rs. 1 lakh 1,603,888 33.97 1,531,918 7,710
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,336,277 49.48 2,247,407 8,117
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,721,662 100.00 4,632,792 8,121

Company Background

Fredun Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Fredun Pharmaceuticals Ltd
  • BSE Code : 5269.0
  • ISIN : INE194R01017
  • Incorporation Year

    1987

  • Registered Office

    26 Manoj Industrial Premises
    G D Ambedkar Marg Wadala, Mumbai,
    Maharashtra-400031

  • Telephone

    91-22-40318111

  • FAX

  • Chairman

    Daulat N Medhora

  • Managing Director

    Fredun N Medhora

  • Company Secretary

  • Auditor

    R.H. Nisar & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Fredun Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fredun Pharma 668.55 349.07 348.16 16.79 16.95
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92